ArticleAnnals of the rheumatic diseases2023

Response to: 'Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'' by Perricone

Binita Shah et al.PubMed ↗Publisher ↗

No numbers read from the abstract.